101 related articles for article (PubMed ID: 785564)
1. Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension.
Yamagami T; Shibata N; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):721-7. PubMed ID: 785564
[TBL] [Abstract][Full Text] [Related]
2. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension.
Yamagami T; Shibata N; Folkers K
Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):273-88. PubMed ID: 1153873
[TBL] [Abstract][Full Text] [Related]
3. Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10.
Folkers K; Drzewoski J; Richardson PC; Ellis J; Shizukuishi S; Baker L
Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):129-40. PubMed ID: 7255868
[TBL] [Abstract][Full Text] [Related]
4. Bioenergetics in clinical medicine. IX. Gingival and leucocytic deficiencies of coenzyme Q10 in patients with periodontal disease.
Hansen IL; Iwamoto Y; Kishi T; Folkers K; Thompson LE
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):729-38. PubMed ID: 959667
[TBL] [Abstract][Full Text] [Related]
5. Bioenergetics in clinical medicine. XI. Studies on coenzyme Q and diabetes mellitus.
Kishi T; Kishi H; Watanabe T; Folkers K
J Med; 1976; 7(3-4):307-21. PubMed ID: 1070515
[TBL] [Abstract][Full Text] [Related]
6. Bioenergetics in clinical medicine. II. Adjunctive treatment with coenzyme Q in periodontal therapy.
Wilkinson EG; Arnold RM; Folkers K; Hansen I; Kishi H
Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):111-23. PubMed ID: 1103247
[TBL] [Abstract][Full Text] [Related]
7. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
Int J Tissue React; 1990; 12(3):163-8. PubMed ID: 2276894
[TBL] [Abstract][Full Text] [Related]
8. Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs.
Kishi H; Kishi T; Folkers K
Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):533-40. PubMed ID: 1197930
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.
Rosenfeldt FL; Haas SJ; Krum H; Hadj A; Ng K; Leong JY; Watts GF
J Hum Hypertens; 2007 Apr; 21(4):297-306. PubMed ID: 17287847
[TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.
Shah SA; Sander S; Cios D; Lipeika J; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):420-5. PubMed ID: 17341532
[TBL] [Abstract][Full Text] [Related]
11. Models for clinical disease. I. Biochemical cardiotoxicity of a coenzyme Q10-inhibitor in rats.
Combs AB; Kishi T; Porter TH; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):333-9. PubMed ID: 1257616
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of activity of succinate dehydrogenase-coenzyme Q10 reductase in leucoytes from patiens with essential hypertension.
Yamagami T; Iwamoto Y; Folkers K
Int J Vitam Nutr Res; 1974; 44(3):404-14. PubMed ID: 4156526
[No Abstract] [Full Text] [Related]
13. Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardium.
Bertazzoli C; Sala L; Ballerini L; Watanabe T; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):797-800. PubMed ID: 1005920
[TBL] [Abstract][Full Text] [Related]
14. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.
Mortensen SA; Vadhanavikit S; Baandrup U; Folkers K
Drugs Exp Clin Res; 1985; 11(8):581-93. PubMed ID: 3836876
[TBL] [Abstract][Full Text] [Related]
15. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome.
Kumar A; Kaur H; Devi P; Mohan V
Pharmacol Ther; 2009 Dec; 124(3):259-68. PubMed ID: 19638284
[TBL] [Abstract][Full Text] [Related]
16. Bioenergetics in clinical medicine XIV. Studies on an apparent deficiency of coenzyme Q-10 in patients with cardiovascular and related diseases.
Folkers K; Watanabe T
J Med; 1978; 9(1):67-79. PubMed ID: 276562
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q10 in dilated cardiomyopathy.
Manzoli U; Rossi E; Littarru GP; Frustaci A; Lippa S; Oradei A; Aureli V
Int J Tissue React; 1990; 12(3):173-8. PubMed ID: 2276896
[TBL] [Abstract][Full Text] [Related]
18. Bioenergetics in clinical medicine. VI. adjunctive treatment of periodontal disease with coenzyme Q10.
Wilkinson EG; Arnold RM; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):715-9. PubMed ID: 785563
[TBL] [Abstract][Full Text] [Related]
19. Research on coenzyme Q10 in clinical medicine and in immunomodulation.
Folkers K; Wolaniuk A
Drugs Exp Clin Res; 1985; 11(8):539-45. PubMed ID: 3836873
[TBL] [Abstract][Full Text] [Related]
20. [Protective effects of coenzyme Q10 on the adverse reactions of anthracycline antibiotics: using double blind method--with special reference to hair loss].
Akihama T; Nakamoto Y; Shindo T; Nakayama Y; Miura A
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2125-9. PubMed ID: 6354099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
